YURAK ISHEMIK KASALLIGIDA INVAZIV VA KONSERVATIV DAVOLASH SAMARADORLIGI
Keywords:
Yurak ishemik kasalligi, invaziv davolash, konservativ davolash, angioplastika, stentlash.Abstract
Mazkur maqolada yurak ishemik kasalligining (YIK) patogenez
mexanizmlari, klinik belgilari hamda davolash strategiyalari keng yoritilgan. Xususan,
invaziv davolash usullari (koronar stentlash, aorto-koronar shuntlash, perkutan koronar
intervensiyalar) va konservativ davolash (farmakoterapiya, parhez, reabilitatsiya)
samaradorligi ilmiy manbalar asosida tahlil qilindi. Turli klinik holatlar va zamonaviy
tavsiyalar asosida YIKni davolashning integrativ yondashuvi muhokama qilinadi.
References
1. Fihn SD, et al. 2019 ACC/AHA guidelines for the management of patients with
stable ischemic heart disease. Circulation.
2. Neumann FJ, et al. ESC/EACTS Guidelines on myocardial revascularization. Eur
Heart J. 2018.
3. Boden WE, et al. COURAGE trial research group. Optimal medical therapy with or
without PCI for stable coronary disease. N Engl J Med. 2007.
4. Maron DJ, et al. Initial invasive or conservative strategy for stable coronary disease.
ISCHEMIA trial, N Engl J Med. 2020.
5. Mohr FW, et al. SYNTAX trial: 10-year outcomes of coronary bypass vs PCI.
Lancet. 2019.
